ey0017.15-8 | (1) | ESPEYB17
B Winzeler , N Cesana-Nigro , J Refardt , DR Vogt , C Imber , B Morin , M Popovic , M Steinmetz , CO Sailer , G Szinnai , I Chifu , M Fassnacht , M Christ-Crain
ey0016.3-16 | New Guidelines | ESPEYB16
L Persani , G Brabant , M Dattani , M Bonomi , U Feldt-Rasmussen , E Fliers , A Gruters , D Maiter , N Schoenmakers , ASP van Trotsenburg
ey0016.5-17 | Basic Science - Bone | ESPEYB16
Y Ikebuchi , S Aoki , M Honma , M Hayashi , Y Sugamori , M Khan , Y Kariya , G Kato , Y Tabata , JM Penninger , N Udagawa , K Aoki , H Suzuki
ey0016.7-13 | Clinical Guidance | ESPEYB16
S Wannes , M Elmaleh-Berges , D Simon , D Zenaty , L Martinerie , C Storey , G Gelwane , A Paulsen , E Ecosse , N De Roux , JC Carel , J Leger
ey0016.8-14 | New Hope | ESPEYB16
K Wiens , SA Berry , H Choi , A Gaviglio , A Gupta , A Hietala , D Kenney-Jung , T Lund , W Miller , EI Pierpont , G Raymond , H Winslow , HA Zierhut , PJ Orchard
ey0015.11-14 | Adipose tissue – a main source of miRNAs | ESPEYB15
W Ying , M Riopel , G Bandyopadhyay , Y Dong , A Birmingham , J Bae Seo , J Ofrecio , J Wollam , A Hernandez-Carretero , W Fu , P Li , J Olefsky
ey0020.5-2 | Clinical Guidance and Studies | ESPEYB20
N Brix , A Gaml-Sorensen , A Ernst , LH Arendt , LL Harrits Lunddorf , G Toft , SS Tottenborg , KK Haervig , BB Hoyer , KS Hougaard , JPE Bonde , CH Ramlau-Hansen
ey0021.6-5 | Clinical and Molecular Insights into SF1 Deficiency | ESPEYB21
C Kouri , G Sommer , I Martinez de Lapiscina , RN Elzenaty , LJW Tack , M Cools , SF Ahmed , CE; SF1next study group Fluck
ey0021.14-12 | Risk and Outcome | ESPEYB21
Wang Zheng , Van Faassen Martijn , Groen Henk , Cantineau Astrid E.P. , Van Oers Anne , Van der Veen Anna , Hawley James M. , Keevil Brian G. , Kema Ido P. , Hoek Annemieke
ey0021.15-4 | New Treatments | ESPEYB21
S Osataphan , M Vamvini , ED Rosen , L Pei , N Erlikh , G Singh , P Dhorajiya , JA Parker , JM Dreyfuss , A Rattani , ME. Patti